Shares of Pharmaniaga Bhd rose during the early trading session on Bursa Malaysia this morning after investors responded to the announcement of the government's latest contract obtained by the group yesterday.
Bernama reported that at 9.48am, the company's counter rose 10 sen to RM5.08 with 1.12 million shares changing hands.
In a filing to Bursa Malaysia yesterday, Pharmaniaga said that its unit, Pharmaniaga Lifescience Sdn Bhd (PLS) is expected to supply 12 million doses of Covid-19 vaccine developed by SINOVAC Life Sciences Co Ltd from China to the Ministry of Health Malaysia (MOH) by April.
The company added that PLS had submitted an application for registration with the National Pharmaceutical Regulatory Division (NPRA) on January 19.
"Subject to NPRA approval, the Covid-19 vaccine is expected to be supplied to the MOH by April," he said.
PLS has signed an agreement with the government for the purchase and distribution of Covid-19 Coronavac, SARS-COV-2 Vaccine (Vero Cell) Inactivated to be supplied to hospitals, clinics and other facilities nationwide as directed by the MOH.
